Kala Pharmaceuticals (KALA) earnings
In the quarter ended June 2026, Kala Pharmaceuticals had revenue of —, and diluted EPS of -21.32.
On August 19, 2026 it reported EPS of -21.32.
The next report is expected on Wednesday, November 18, 2026.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Wed Nov 18, 2026 | — | — | — |
| Last | Wed Aug 19, 2026 | — | — | -21.32 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from Kala Pharmaceuticals's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | -21.32 | — | — | 2026-08-19 |
| Mar 31, 2026 | — | — | -0.14 | — | — | 2026-05-15 |
| Dec 31, 2025 | — | — | — | — | — | 2026-04-15 |
| Sep 30, 2025 | — | — | -53.50 | — | — | 2025-11-19 |
| Jun 30, 2025 | — | — | -85.64 | — | — | 2025-08-08 |
| Mar 31, 2025 | — | — | -70.49 | — | — | 2025-05-14 |
| Dec 31, 2024 | — | — | — | — | — | 2025-03-31 |
| Sep 30, 2024 | — | — | -96.50 | — | — | 2024-11-12 |
| Jun 30, 2024 | — | — | -158.00 | — | — | 2024-08-06 |
| Mar 31, 2024 | — | — | -210.00 | — | — | 2024-05-14 |
| Dec 31, 2023 | — | — | — | — | — | 2024-03-29 |
| Sep 30, 2023 | — | — | -170.50 | -117.7% | — | 2023-11-13 |
Questions
When does Kala Pharmaceuticals report earnings?
Kala Pharmaceuticals's next earnings report is expected on November 18, 2026.
How did Kala Pharmaceuticals do last quarter?
In the quarter ended June 2026, Kala Pharmaceuticals had revenue of —, and diluted EPS of -21.32.
From Kala Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.